“Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study”, Swiss Med Wkly, vol. 153, no. 3, p. 40055, Mar. 2023, doi: 10.57187/smw.2023.40055.